Redmile Group’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$8.38M Sell
2024
Q4
$14.2M Sell
2024
Q3
$18.3M Sell
2024
Q2
$19M Sell
2024
Q1
$31.3M Sell
2023
Q4
$41.2M Sell
2023
Q3
$42.3M Sell
2023
Q2
$36.4M Buy
2023
Q1
$20.4M Buy
2022
Q4
$19.3M Buy
2020
Q4
Sell
2020
Q3
$4.26M Sell
2020
Q2
$14.6M Buy